FDA releases guidance for remotely acquiring data in clinical investigations
Healthcare IT News - Telehealth
JANUARY 3, 2022
"Compared to intermittent trial visits, the use of DHTs to remotely collect data from trial participants may allow for continuous or more frequent data collection," said FDA officials. The FDA notes that digital health tools used for remote data acquisition can offer an important role in clinical research. WHY IT MATTERS.
Let's personalize your content